tacrolimus

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

TACROLIMUS — NEXUS, approved 2025-02-12 (ANDA217108).

Most reported adverse events (US / FAERS)

87,860 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

off label use

14,698

drug ineffective

10,091

drug interaction

6,337

product use in unapproved indication

6,250

Medicines containing this active substance

5 medicines

🇺🇸 Also approved in the US (FDA)

TACROLIMUS — NEXUS, approved 2025-02-12 (ANDA217108).

Most reported adverse events (US / FAERS)

87,860 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

off label use

14,698

drug ineffective

10,091

drug interaction

6,337

product use in unapproved indication

6,250

acute kidney injury

5,969

diarrhoea

5,856

death

4,997

transplant rejection

4,984

pyrexia

4,813

cytomegalovirus infection

4,560

pneumonia

4,475

covid-19

3,927

toxicity to various agents

3,812

renal impairment

3,627

sepsis

3,464